News25/Ratings0
Price$1.05-6.43 (-85.96%)
2026-07-162026-10-16
News · 26 weeks72-22%
2026-04-192026-10-11
Mix3890d
- SEC Filings16(42%)
- Insider13(34%)
- Other8(21%)
- Offering1(3%)
Latest news
25 items- PRProfusa Receives ISO 13485:2016 Certificate from GMEDProviding a Foundational Quality Management System (QMS) for Commercialization Certificate issued by GMED, an EU MDR notified body, following the positive certification decision previously announcedISO 13485 certification supports ongoing MDR conformity assessment activities for the Lumee Oxygen Platform and represents an important milestone toward MDR certification and CE marking. BERKELEY, Calif., Oct. 15, 2026 (GLOBE NEWSWIRE) -- Profusa, Inc. (NASDAQ:PFSA) ("Profusa" or the "Company"), a digital health company pioneering next-generation biosensor technologies, today announced that it has received its ISO 13485:2016 certificate from GMED, a notified body designated
- SECSEC Form 8-K filed by Profusa Inc.8-K - Profusa, Inc. (0001859807) (Filer)
- SECSEC Form 8-K filed by Profusa Inc.8-K - Profusa, Inc. (0001859807) (Filer)
- SECProfusa Inc. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Creation of a Direct Financial Obligation, Financial Statements and Exhibits8-K - Profusa, Inc. (0001859807) (Filer)
- PRHere’s What Investors Are Watching, Including $20 Price Target BombshellDENVER, Sept. 24, 2026 (GLOBE NEWSWIRE) -- (247marketnews.com) -- These companies are stepping into the market spotlight with very different catalysts: NeOnc (NASDAQ:NTHI) is drawing Wall Street attention around its brain-cancer pipeline and a $20 price target; Profusa (NASDAQ:PFSA) is advancing the regulatory path for its Lumee Oxygen Platform; Apimeds Pharmaceuticals US (NYSEAMERICAN:APUS) is expanding into blockchain-powered ecosystem finance through its MindWave Innovations subsidiary; and Greenland Energy Company (NASDAQ:GLND) has extended the timeline for its Jameson Land exploration program in East Greenland. NeOnc Technologies Holdings: Wall Street Puts $20 Target on the Brain-Can
- PRProfusa Announces Significant Progress Towards Lumee® Oxygen Platform CE Mark with ISO 13485 Certification Expected in Early OctoberBERKELEY, CA, Sept. 24, 2026 (GLOBE NEWSWIRE) -- Profusa, Inc. (NASDAQ:PFSA), a digital health company pioneering next-generation biosensor technologies today announced that the Company has received a positive decision from GMED regarding certification of its quality management system to ISO 13485. GMED is a notified body designated under the European Union Medical Device Regulation (MDR). The Company continues to work with GMED toward completion of the remaining applicable MDR conformity assessment activities for the Lumee® Oxygen Platform. Successful completion of these activities would support issuance of the applicable MDR certificate and the Company's subsequent CE marking of the Lum
- SECProfusa Inc. filed SEC Form 8-K: Submission of Matters to a Vote of Security Holders8-K - Profusa, Inc. (0001859807) (Filer)
- SECProfusa Inc. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Creation of a Direct Financial Obligation, Financial Statements and Exhibits8-K - Profusa, Inc. (0001859807) (Filer)
- SECProfusa Inc. filed SEC Form 8-K: Other Events, Financial Statements and Exhibits8-K - Profusa, Inc. (0001859807) (Filer)
- PRProfusa, Inc. Receives Nasdaq Compliance DeterminationBerkeley, CA, Sept. 15, 2026 (GLOBE NEWSWIRE) -- Profusa, Inc. (NASDAQ:PFSA) (the "Company") announced today that on September 9, 2026, the Company received a letter (the "Compliance Determination Letter") from The Nasdaq Stock Market LLC ("Nasdaq") confirming that the Company has demonstrated compliance with Nasdaq Listing Rule 5550(a)(2) (the "Bid Price Rule") and Nasdaq Listing Rule 5550(b)(1) (the "Equity Rule"). The Company remains subject to a one-year Mandatory Panel Monitor (the "Monitoring Period"). If during the Monitoring Period the Company fails to satisfy the equity rule, the company will not be provided the opportunity to submit a compliance plan; rather, Nasdaq will issue
- INSIDERChief Executive Officer Stover Jack E acquired 32,018 shares and disposed of 301,991 shares, increasing direct ownership by 43,860% to 32,091 units (SEC Form 4)4 - Profusa, Inc. (0001859807) (Issuer)
- INSIDERChief Financial Officer Knechtel Fred S. disposed of 301,991 shares and acquired 54,323 shares, increasing direct ownership by 36,954% to 54,470 units (SEC Form 4)4 - Profusa, Inc. (0001859807) (Issuer)
- SECProfusa Inc. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Creation of a Direct Financial Obligation, Financial Statements and Exhibits8-K - Profusa, Inc. (0001859807) (Filer)
- SECProfusa Inc. filed SEC Form 8-K: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing, Financial Statements and Exhibits8-K - Profusa, Inc. (0001859807) (Filer)
- PRProfusa, Inc. Announces Compliance with Nasdaq Publicly Held Shares RequirementBerkeley, CA, Aug. 31, 2026 (GLOBE NEWSWIRE) -- Profusa, Inc. (NASDAQ:PFSA) (the "Company") announced that it has received a letter (the "Notice") from the Listing Qualifications Department of The Nasdaq Stock Market LLC ("Nasdaq") stating that on August 14, 2026, following the effectiveness of the Company’s 1-for-4 reverse stock split, the Company had less than the 500,000 publicly held shares required under Nasdaq Listing Rule 5550(a)(4) (the "Rule"). The Notice further stated that based on the Company’s correspondence with Nasdaq on August 21, 2026, Nasdaq has determined that the Company complies with the Rule as of August 21, 2026, and that Nasdaq’s review of the Company’s compliance
- SECSEC Form DEF 14A filed by Profusa Inc.DEF 14A - Profusa, Inc. (0001859807) (Filer)
- SECProfusa Inc. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Creation of a Direct Financial Obligation, Unregistered Sales of Equity Securities, Financial Statements and Exhibits8-K - Profusa, Inc. (0001859807) (Filer)
- SECProfusa Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits8-K - Profusa, Inc. (0001859807) (Filer)
- PRProfusa Announces Q2 2026 Financial Results and Progress on the Option Agreement Conditions to Close with G3 Vision Labs, a Commercial Stage Diagnostics CompanyDebt and liabilities holders have executed $10.7 million of Series A Convertible Exchange Agreements; of which $4.57 million was converted into Series A Convertible Preferred Stock Sufficient working capital obtained to fund operations for near term PCAOB audited 2024 and 2025 financials of G3 and Subsidiaries are expected by mid-September Reverse stock split successfully executed August 20, 2026 BERKELEY, Calif., Aug. 20, 2026 (GLOBE NEWSWIRE) -- Profusa, Inc. (NASDAQ:PFSA), a digital health company pioneering next-generation biosensor technologies, previously announced the signing of an Option Agreement (the "Agreement") which provides Profusa the right and option, but not the obli
- INSIDERChief Financial Officer Knechtel Fred S. converted options into 301,991 shares (SEC Form 4)4 - Profusa, Inc. (0001859807) (Issuer)
- INSIDERChief Executive Officer Stover Jack E converted options into 301,991 shares (SEC Form 4)4 - Profusa, Inc. (0001859807) (Issuer)
- SECSEC Form 10-Q filed by Profusa Inc.10-Q - Profusa, Inc. (0001859807) (Filer)
- INSIDERLarge owner Hrt Financial Lp sold $109,266 worth of shares (18,395 units at $5.94), closing all direct ownership in the company (SEC Form 4)4 - Profusa, Inc. (0001859807) (Issuer)
- SECSEC Form PRE 14A filed by Profusa Inc.PRE 14A - Profusa, Inc. (0001859807) (Filer)
- INSIDERLarge owner Hrt Financial Lp sold $2,853 worth of shares (3,163 units at $0.90), decreasing direct ownership by 4% to 71,035 units (SEC Form 4)4 - Profusa, Inc. (0001859807) (Issuer)
PFSA FAQ
4 questionsWhere does PFSA stock trade?
Profusa Inc. (PFSA) is listed on NASDAQ.What sector and industry is PFSA in?
Profusa Inc. operates in the Health Care sector, Medical/Dental Instruments industry.What companies are similar to PFSA?
Notable peers in the same industry include SYK (Stryker Corporation), MMM (3M Company), BSX (Boston Scientific Corporation), BDX (Becton Dickinson and Company), MDLN (Medline Inc.). Compare PFSA side-by-side with any of them on Quantisnow.How can I track PFSA on Quantisnow?
Quantisnow aggregates Profusa Inc.'s SEC filings, analyst ratings, insider transactions, FDA approvals, and press releases the moment they hit the wire (Wall Street's wire, on your screen.). Follow PFSA to receive live email and push alerts on every new disclosure.